Genmab reports top line results in Phase III DLBCL trial

Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting ...
The Manila Times

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of ...

ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

ENHERTU Plus Pertuzumab Type II Variation Application Validated in EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...
Pharmabiz

AbbVie reports positive results from phase 3 EPCORE DLBCL-1 trial of epcoritamab in patients with r/r diffuse large B-cell lymphoma

North Chicago, Illinois Monday, January 19, 2026, 15:00 Hrs [IST] ...

Breakthrough Experiment: How We Can Stop the Spread of Flu

A surprising flu experiment shows that good airflow and fewer coughs can stop the virus from spreading, even up close.
Edzard Ernst

Pulsed electromagnetic field therapy for non-specific low back pain?

Non-specific low back pain is a common condition with substantial socioeconomic implications. Pulsed electromagnetic field (PEMF) therapy is said to generate benefits in pain reduction and improvement ...